Report overview
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years.
This report aims to provide a comprehensive presentation of the global market for Biological Vaccines Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Vaccines Adjuvants. This report contains market size and forecasts of Biological Vaccines Adjuvants in global, including the following market information:
Global Biological Vaccines Adjuvants Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biological Vaccines Adjuvants Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biological Vaccines Adjuvants companies in 2022 (%)
The global Biological Vaccines Adjuvants market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Aluminum Adjuvant Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biological Vaccines Adjuvants include GSK, Dynavax Technologies, Novavax, Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health Corporation and Associated British Foods, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biological Vaccines Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biological Vaccines Adjuvants Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biological Vaccines Adjuvants Market Segment Percentages, by Type, 2022 (%)
Aluminum Adjuvant
Emulsions Adjuvant
Others
Global Biological Vaccines Adjuvants Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biological Vaccines Adjuvants Market Segment Percentages, by Application, 2022 (%)
Human Vaccine
Veterinary Vaccine
Global Biological Vaccines Adjuvants Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biological Vaccines Adjuvants Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biological Vaccines Adjuvants revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biological Vaccines Adjuvants revenues share in global market, 2022 (%)
Key companies Biological Vaccines Adjuvants sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biological Vaccines Adjuvants sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Dynavax Technologies
Novavax
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health Corporation
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
Vertellus
Allergy Therapeutics
Riboxx GmbH
CaPtivat? Pharmaceuticals
EuBiologics
Pacific GeneTech
Hawaii Biotech
Vaxine Pty Ltd.
Creative Diagnostics
LiteVax BV
Mukta Industries
Oncovir
TiterMax USA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biological Vaccines Adjuvants, market overview.
Chapter 2: Global Biological Vaccines Adjuvants market size in revenue and volume.
Chapter 3: Detailed analysis of Biological Vaccines Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biological Vaccines Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biological Vaccines Adjuvants capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
